It can also downregulate the EGFR/STAT3/cyclin-D1/survivin and NF-κB/IκBα/cyclin-D1/survivin pathways, leading to apoptosis in pancreatic cancer cells (PANC-1) [91]. Here, BIRC5 is linked to familial pancreatic carcinoma.